Source: Virtual Congress 2021 – Diagnosis and management of COVID-19



Rating:

Share or cite this content

Citations should be made in the following way:
F. Bini (Garbagnate Milanese, Italy), B. Bodini (Garbagnate Milanese, Italy), M. Bongiovanni (Garbagnate Milanese, Italy), A. De Lauretis (Garbagnate Milanese, Italy), A. Marra (Garbagnate Milanese, Italy), A. Pistone (Garbagnate Milanese, Italy), N. Grassi (Garbagnate Milanese, Italy). Clinical features and outcome of COVID-19 pneumonia in haemodialysis patients. 451

Member's Comments

No comment yet.

Related content which might interest you: Clinical features of COVID-19 pneumonia in elderly patients Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021 Clinical epidemiology of pneumonia in hemodialysis patients Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012 Clinical characteristics and outcomes in hospitalized COVID-19 patients with COPD Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021 Clinical outcome and prognostic factors of acute respiratory failure due to pneumocystis pneumonia in non-HIV patients Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 Clinical characteristics of pneumonia in the elderly Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections Year: 2010 Clinical features and prognostic factors in elderly patients with aspiration pneumonia Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012 Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections Year: 2009 Clinical characteristics and outcome of patients with empyema and hepatic cirrhosis Source: Annual Congress 2010 - Unusual pathogens in respiratory infections Year: 2010 Prospective evaluation of clinical and microbiological parameters in patients with community-acquired pneumonia with and without comorbidity Source: Eur Respir J 2006; 28: Suppl. 50, 530s Year: 2006 Clinical features, outcome and factors associated with mortality in patients with Nocardia pneumonia Source: Annual Congress 2012 - Viral infections and rare respiratory infections Year: 2012 Etiology and clinical outcome of community-acquired pneumonias in hospitalized children Source: Eur Respir J 2007; 30: Suppl. 51, 398s Year: 2007 Clinical prognostic factors for pneumocystis pneumonia in non-HIV patients Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012 Criteria for clinical stability in hospitalised patients with community-acquired pneumonia Source: Eur Respir J 2013; 42: 742-749 Year: 2013 Clinical signs and symptoms as predictors of pneumonia in hospitalized children Source: Annual Congress 2008 - Miscellaneous respiratory infections Year: 2008 Clinical factors associated with delayed diagnosis in hospitalized community-acquired pneumonia (CAP). Impact on the outcome Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia Year: 2010 Impact of nosocomial pneumonia on the outcome of mechanically-ventilated patients Source: Eur Respir J 2004; 24: Suppl. 48, 548s Year: 2004 Clinical features and acute management of COVID-19 in children Source: Eur Respir Monogr 2021; 94: 144-161 Year: 2021 Early outcomes in CAP: clinical stability, clinical failure and nonresolving pneumonia Source: Eur Respir Monogr 2014; 63: 205-218 Year: 2014 Characteristics of hospitalized COVID-19 patients and parameters associated with severe pneumonia Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021 Prognostic evaluation of COPD patients with pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 257s Year: 2005